Diabetes Type II Clinical Trial
Official title:
A Feasibility Study of DermGEN Dermal Regeneration Scaffold for the Treatment of Diabetic Foot Ulcers
The purpose of this clinical trial is to perform a limited pilot study to determine the safety and feasibility of DermGEN in the treatment of non-healing diabetic foot ulcers (DFU). This will be a one-arm prospective study. It is hypothesized that DermGEN treatment will result in positive healing outcomes with no significant adverse effects.
This will be a one-arm prospective study. This study in Halifax will be mirrored in one other participating health care center in Toronto, Ontario, Canada with each centre anticipated to enrol 5-10 patients for a total of 15-20 patients. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01713764 -
A Pilot Study of the Effects of Diet and Behavioral Interventions on Health in Diabetics
|
Phase 2 | |
| Completed |
NCT01121315 -
A Retrospective Study of Cardiovascular Events Related to the Use of Glucose Lowering Drug Treatment in Primary Care
|
N/A | |
| Completed |
NCT02773095 -
Evaluation of Novartis Access; a Non-communicable Disease (NCD) Access Initiative
|
N/A | |
| Recruiting |
NCT02361489 -
Clinical Study to Compare Various Dosing and Titration Guidelines of Insulin Delivered Via V-Go ® in Patients With Type 2 Diabetes Initiating Basal Bolus Therapy in Primary Care Offices
|
Phase 4 | |
| Completed |
NCT02326129 -
Novel Biomarker for Development of T2D
|
||
| Not yet recruiting |
NCT02074540 -
The Influence of Health Beliefs and Uncertainty on Diabetes Type II Patient Compliance
|
N/A |